½ÃÀ庸°í¼­
»óǰÄÚµå
1823784

DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

DNA and RNA Sample Preparation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå¿¡ °üÇÑ ±¤¹üÀ§ÇÑ ¸®Æ÷Æ®¸¦ ¹ßÇàÇß½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µîÀÇ ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ ½ÉÃþ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå ±Ô¸ð(2025 E) : 21¾ï 2,000¸¸ ´Þ·¯
  • ¿¹Ãø ½ÃÀå °¡Ä¡(2032 F) : 31¾ï 1,000¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2025-2032³â) : 5.7%

DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå - Á¶»ç ¹üÀ§ :

DNA ¹× RNA »ùÇà Áغñ ½ÃÀå¿¡´Â DNA ¹× RNA »ùÇÃÀ» È¿À²ÀûÀ¸·Î ÃßÃâ, Á¤Á¦ ¹× ó¸®Çϵµ·Ï ¼³°èµÈ ´Ù¾çÇÑ ½Ã¾à, ŰƮ, ÀÚµ¿È­ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ Á¦Ç°µéÀº À¯ÀüüÇÐ, ºÐÀÚÁø´Ü, ½Å¾à°³¹ß, ¹ýÀÇÇÐ ºÐ¼® µî ´Ù¾çÇÑ ¿ëµµ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀº Çмú¿¬±¸±â°ü, »ý¸í°øÇÐ ¹× Á¦¾à±â¾÷, º´¿ø, Áø´Ü¿¬±¸¼Ò µî ´Ù¾çÇÑ ºÎ¹®¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ³ôÀº 󸮷® ½ÃÄö½Ì¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ºÐÀÚ»ý¹°ÇÐ ±â¼úÀÇ ¹ßÀü, À¯Àü¼º Áúȯ ¹× °¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°è DNA ¹× RNA »ùÇà Áغñ ½ÃÀåÀ» ÁÖµµÇÏ´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ¹× ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ±â¼úÀÇ Ã¤ÅÃÀÌ È®´ëµÇ¸é¼­ È¿À²ÀûÀÎ ½Ã·á Àüó¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­µÈ ½Ã·á Áغñ ¿öÅ©Ç÷οìÀÇ ±â¼ú ¹ßÀüÀº È¿À²¼º°ú ÀçÇö¼ºÀ» ³ôÀ̰í, ¿À¿° ¹× ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ ¿¬±¸¿Í ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½Å¼ÓÇÏ°í °íǰÁúÀÇ ÇÙ»ê ÃßÃâ¹ý¿¡ ´ëÇÑ ¼ö¿ä´Â °¨¿°º´ ¹ß»ý°ú ¾Ï ¿¬±¸ Áõ°¡·Î ÀÎÇØ ´õ¿í ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÃßÃâ ŰƮ ¹× ½Ã¾àÀÇ ±â¼ú Çõ½Å°ú ÇÔ²² ¿¬±¸°³¹ß Ȱµ¿ÀÌ °­È­µÇ¾î ´Ù¾çÇÑ ¿ëµµ¿¡ º¸´Ù °ß°íÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

DNA ¹× RNA ½Ã·á Áغñ ½ÃÀåÀº À¯¸Á ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í °í±Þ ½Ã·á Áغñ ŰƮ ¹× ÀÚµ¿È­ ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë¿¡ ´ëÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¿¬±¸±â°üÀ̳ª ¼Ò±Ô¸ð Áø´Ü¿¬±¸¼Ò´Â ¿¹»êÀÇ Á¦¾àÀ¸·Î ÀÎÇØ ÇÁ¸®¹Ì¾ö ±â¼ú¿¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ´É·ÂÀÌ Á¦ÇÑµÇ¾î ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Ã·á Áغñ ÇÁ·ÎÅäÄÝÀÇ º¹À⼺°ú Àü¹® Áö½ÄÀÇ Çʿ伺ÀÌ º¸±Þ¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á÷Á¢ ½Ã·á ºÐ¼®, ÇöÀå °Ë»ç µî ´ëü ±â¼úÀÇ Á¸Àçµµ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ½Ã·á Áغñ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ:

ÀÌ ½ÃÀåÀº ½Ã·á Áغñ ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­ ¹× ¼ÒÇüÈ­ äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Å« ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¾×ü»ý°Ë°ú ºñħ½ÀÀû Áø´Ü ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ »õ·Î¿î DNA ¹× RNA ÃßÃâ ŰƮ °³¹ßÀÇ »õ·Î¿î ±æÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù. ´ÜÀϼ¼Æ÷ ½ÃÄö½Ì°ú ¸ÞŸÀ¯ÀüüÀÇ ¹ßÀüÀº ´õ ±íÀº »ý¹°ÇÐÀû ÀλçÀÌÆ®¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ½ÃÀåÀÇ °¡´É¼ºÀ» ´õ¿í È®´ëÇÒ °ÍÀÔ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸ÀÇ È®´ë¿Í ÇÙ»ê ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, Áö¼Ó°¡´ÉÇϰí ģȯ°æÀûÀÎ ½Ã¾à¿¡ ´ëÇÑ ÅõÀÚ, ³ôÀº ¼öÀ²°ú ¿À¿°ÀÌ ¾ø´Â ½Ã·á Áغñ Á¦Ç°ÀÇ µµÀÔÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • DNA ¹× RNA »ùÇà Áغñ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¾î¶² ½Ã·á Áغñ ±â¼ú°ú Á¦Ç°ÀÌ ´Ù¾çÇÑ ¿ëµµ¿¡¼­ äÅÃÀ» ÁÖµµÇϰí Àִ°¡?
  • ±â¼ú ¹ßÀüÀº DNA ¹× RNA »ùÇà Áغñ ½ÃÀåÀÇ °æÀï ȯ°æ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?
  • DNA ¹× RNA »ùÇà Áغñ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è DNA ¹× RNA »ùÇà Áغñ ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú ¹Ì·¡ Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°è GDP ¼ºÀå Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° äÅà ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ëÀû ¸ÅÃâ ±âȸ
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
  • ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á : Á¦Ç°
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, Á¦Ç°º°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2025-2032³â
      • ¿öÅ©½ºÅ×À̼Ç
      • ŰƮ
        • DNA »ùÇà Á¶Á¦
        • RNA »ùÇà Á¶Á¦
      • ½Ã¾à ¹× ¼Ò¸ðǰ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á : ¿ëµµ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð, ¿ëµµº°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2025-2032³â
      • ÀÓ»ó½ÃÇè
      • Áø´Ü °Ë»ç
      • Á¶»ç ½Åû
      • ±âŸ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµ
  • ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2025-2032³â
      • º´¿ø
      • Áø´Ü ¼¾ÅÍ
      • ¹ýÀÇÇÐ ¿¬±¸¼Ò
      • Çмú Á¶»ç±â°ü
      • ±âŸ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ

Á¦5Àå ¼¼°èÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, Áö¿ªº°, 2019-2024³â
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2025-2032³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ DNA ¹× RNA »ùÇà Á¶Á¦ ½ÃÀå Àü¸Á

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2025³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °ÝÈ­ ¸Ê
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Thermo Fisher Scientific Inc.
    • Isogen Lifescience BV
    • MP Biomedicals
    • Minerva Biolabs GmbH
    • QIAGEN
    • Bio-Rad Laboratories, Inc
    • Merck KGaA
    • Agilent Technologies, Inc.
    • c-LEcta GmbH
    • Beckman Coulter, Inc.
    • Bioresearch Technologies
    • Promega Corporation
    • Illumina, Inc.
    • Aurora Biomed Inc.
    • Hygiena LLC
    • Tecan Trading AG
    • MACHEREY-NAGEL GmbH &Co. KG
    • Ahlstrom
    • Nanodigmbio(Nanjing) Biotechnology Co., Ltd.
    • Bionano Genomics, Inc.
    • Revvity
    • F. Hoffmann-La Roche Ltd
    • New England Biolabs

Á¦13Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦
  • µÎÀÚ¾î¿Í ¾à¾î
KSA

Persistence Market Research has recently published an extensive report on the global DNA and RNA Sample Preparation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • DNA and RNA Sample Preparation Market Size (2025E): USD 2.12 Bn
  • Projected Market Value (2032F): USD 3.11 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.7%

DNA and RNA Sample Preparation Market - Report Scope:

The DNA and RNA Sample Preparation Market encompasses a variety of reagents, kits, and automated instruments designed to extract, purify, and process DNA and RNA samples efficiently. These products are crucial for various applications, including genomics, molecular diagnostics, drug discovery, and forensic analysis. The market serves diverse segments such as academic research institutes, biotechnology and pharmaceutical companies, hospitals, and diagnostic laboratories. Growth is driven by increasing demand for high-throughput sequencing, advancements in molecular biology techniques, and the rising prevalence of genetic disorders and infectious diseases.

Market Growth Drivers:

Several key factors are driving the global DNA and RNA Sample Preparation Market. The growing adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies is boosting demand for efficient sample preparation solutions. Technological advancements in automated sample preparation workflows enhance efficiency and reproducibility, reducing the risk of contamination and human error. Additionally, increasing investments in genetic research and personalized medicine are fueling market growth. The demand for rapid and high-quality nucleic acid extraction methods is further propelled by the rise in infectious disease outbreaks and cancer research. Enhanced research and development activities, along with innovations in extraction kits and reagents, contribute to market growth by offering more robust solutions for various applications.

Market Restraints:

Despite promising growth prospects, the DNA and RNA Sample Preparation Market faces challenges related to high costs associated with advanced sample preparation kits and automated systems. Market expansion may be hindered by budget constraints in research institutions and small diagnostic laboratories, limiting their ability to invest in premium technologies. Additionally, the complexity of sample preparation protocols and the need for specialized expertise pose challenges for widespread adoption. The presence of alternative techniques, such as direct sample analysis and point-of-care testing, may also impact market growth. Addressing these issues requires continuous innovation in cost-effective and user-friendly sample preparation solutions.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of automation and miniaturization in sample preparation workflows. The rising focus on liquid biopsy and non-invasive diagnostic techniques opens new avenues for the development of novel DNA and RNA extraction kits. Advancements in single-cell sequencing and metagenomics further expand the market's potential by enabling deeper biological insights. The expansion of biopharmaceutical research and the growing demand for nucleic acid-based therapeutics present lucrative growth prospects. Strategic partnerships, investments in sustainable and eco-friendly reagents, and the introduction of high-yield and contamination-free sample preparation products are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the DNA and RNA Sample Preparation Market globally?
  • Which sample preparation techniques and products are leading the adoption in various applications?
  • How are technological advancements influencing the competitive landscape of the DNA and RNA Sample Preparation Market?
  • Who are the key players in the DNA and RNA Sample Preparation Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global DNA and RNA Sample Preparation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global DNA and RNA Sample Preparation Market, including Thermo Fisher Scientific, QIAGEN, and Promega Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced sample preparation solutions and explore new automation technologies. Collaborations with research institutions, diagnostic laboratories, and pharmaceutical companies facilitate market access and promote new product adoption. Emphasis on quality assurance, regulatory compliance, and comprehensive marketing strategies fosters market growth and enhances brand reputation in the evolving DNA and RNA Sample Preparation Market landscape.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • QIAGEN
  • Merck Millipore
  • Tecan Group AG

DNA and RNA Sample Preparation Market Industry Segmentation

By Product

  • Workstations
  • Kits
  • DNA Sample Preparation
  • RNA Sample Preparation
  • Reagent and Consumables

By Application

  • Clinical Testing
  • Diagnostic Testing
  • Research Application
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Forensic Science Laboratories
  • Academic and Research Institutions
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global DNA and RNA Sample Preparation Market Outlook
  • 1.2. Market DNA and RNA Sample Preparation Market Outlook: Services
  • 1.3. Introduction/Key Findings
  • 1.4. Historical Market Size (US$ Bn ) and Analysis, By Services, 2019-2024
  • 1.5. Current Market Size (US$ Bn ) and Analysis and Forecast, By Services, 2025-2032
  • 1.6. Future Market Projections
  • 1.7. Premium Market Insights
  • 1.8. Industry Developments and Key Market Events
  • 1.9. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Global DNA and RNA Sample Preparation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn ) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
  • 4.3. Global DNA and RNA Sample Preparation Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn ) Analysis, By Product, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
      • 4.3.3.1. Workstations
      • 4.3.3.2. Kits
        • 4.3.3.2.1. DNA Sample Preparation
        • 4.3.3.2.2. RNA Sample Preparation
      • 4.3.3.3. Reagent and Consumables
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global DNA and RNA Sample Preparation Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn ), By Application, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Clinical Testing
      • 4.4.3.2. Diagnostic Testing
      • 4.4.3.3. Research Application
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global DNA and RNA Sample Preparation Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn ) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic Centers
      • 4.5.3.3. Forensic Science Laboratories
      • 4.5.3.4. Academic & Research Institutions
      • 4.5.3.5. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global DNA and RNA Sample Preparation Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America DNA and RNA Sample Preparation Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 6.4.1. Workstations
    • 6.4.2. Kits
      • 6.4.2.1. DNA Sample Preparation
      • 6.4.2.2. RNA Sample Preparation
    • 6.4.3. Reagent and Consumables
  • 6.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Clinical Testing
    • 6.5.2. Diagnostic Testing
    • 6.5.3. Research Application
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic Centers
    • 6.6.3. Forensic Science Laboratories
    • 6.6.4. Academic & Research Institutions
    • 6.6.5. Others
  • 6.7. Market Attractiveness Analysis

7. Europe DNA and RNA Sample Preparation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Workstations
    • 7.4.2. Kits
      • 7.4.2.1. DNA Sample Preparation
      • 7.4.2.2. RNA Sample Preparation
    • 7.4.3. Reagent and Consumables
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Clinical Testing
    • 7.5.2. Diagnostic Testing
    • 7.5.3. Research Application
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Centers
    • 7.6.3. Forensic Science Laboratories
    • 7.6.4. Academic & Research Institutions
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia DNA and RNA Sample Preparation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Workstations
    • 8.4.2. Kits
      • 8.4.2.1. DNA Sample Preparation
      • 8.4.2.2. RNA Sample Preparation
    • 8.4.3. Reagent and Consumables
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Clinical Testing
    • 8.5.2. Diagnostic Testing
    • 8.5.3. Research Application
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Centers
    • 8.6.3. Forensic Science Laboratories
    • 8.6.4. Academic & Research Institutions
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania DNA and RNA Sample Preparation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Workstations
    • 9.4.2. Kits
      • 9.4.2.1. DNA Sample Preparation
      • 9.4.2.2. RNA Sample Preparation
    • 9.4.3. Reagent and Consumables
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Clinical Testing
    • 9.5.2. Diagnostic Testing
    • 9.5.3. Research Application
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Centers
    • 9.6.3. Forensic Science Laboratories
    • 9.6.4. Academic & Research Institutions
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America DNA and RNA Sample Preparation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Workstations
    • 10.4.2. Kits
      • 10.4.2.1. DNA Sample Preparation
      • 10.4.2.2. RNA Sample Preparation
    • 10.4.3. Reagent and Consumables
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Clinical Testing
    • 10.5.2. Diagnostic Testing
    • 10.5.3. Research Application
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Centers
    • 10.6.3. Forensic Science Laboratories
    • 10.6.4. Academic & Research Institutions
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa DNA and RNA Sample Preparation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Workstations
    • 11.4.2. Kits
      • 11.4.2.1. DNA Sample Preparation
      • 11.4.2.2. RNA Sample Preparation
    • 11.4.3. Reagent and Consumables
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Clinical Testing
    • 11.5.2. Diagnostic Testing
    • 11.5.3. Research Application
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Centers
    • 11.6.3. Forensic Science Laboratories
    • 11.6.4. Academic & Research Institutions
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Isogen Lifescience B.V.
    • 12.3.3. MP Biomedicals
    • 12.3.4. Minerva Biolabs GmbH
    • 12.3.5. QIAGEN
    • 12.3.6. Bio-Rad Laboratories, Inc
    • 12.3.7. Merck KGaA
    • 12.3.8. Agilent Technologies, Inc.
    • 12.3.9. c-LEcta GmbH
    • 12.3.10. Beckman Coulter, Inc.
    • 12.3.11. Bioresearch Technologies
    • 12.3.12. Promega Corporation
    • 12.3.13. Illumina, Inc.
    • 12.3.14. Aurora Biomed Inc.
    • 12.3.15. Hygiena LLC
    • 12.3.16. Tecan Trading AG
    • 12.3.17. MACHEREY-NAGEL GmbH & Co. KG
    • 12.3.18. Ahlstrom
    • 12.3.19. Nanodigmbio (Nanjing) Biotechnology Co., Ltd.
    • 12.3.20. Bionano Genomics, Inc.
    • 12.3.21. Revvity
    • 12.3.22. F. Hoffmann-La Roche Ltd
    • 12.3.23. New England Biolabs

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦